Capecitabine plus irinotecan with or without apatinib for advanced colorectal cancer: an open label, controlled, prospective phase II trial
收藏NIAID Data Ecosystem2026-03-10 收录
官方服务：
资源简介：
Interventions: Group 2:capecitabine combined with irinotecan and apatinib;Group 1:capecitabine combined with irinotecan Primary outcome(s): PFS Study Design: Non randomized control
创建时间：
2018-11-15
